Exalenz Bioscience Launches H. Pylori Breath Test

Exalenz Biosciences, a Jersey City, N.J.-based GI and liver condition diagnostic medical device development company, has announced the global launch of its BreathID Hp.

Advertisement

The BreathID Hp is designed as a non-invasive, quick and accurate test for the detection of H. pylori.

More Articles on Gastroenterology:
4 GI Devices Receive FDA 510(k) Clearance in May & June
FDA Will Not Require IND for Fecal Microbiota Transplant
Endoscopy Device Market to be Worth $4.3B by 2017

Advertisement

Next Up in GI & Endoscopy

  • Below is a list of five gastroenterology leaders in the U.S. who have made a positive impact on their organizations…

  • Chicago-based GI Partners of Illinois saw its GI case mix tilt toward more complex, chronic and multidisciplinary care in 2025,…

Advertisement

Comments are closed.